|
Market Closed -
Nasdaq
23:00:00 09/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 83.88 USD | -0.77% |
|
-6.48% | +26.38% |
| 09-09 | DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM | |
| 08-24 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 31,653 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 22.28% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 30,892 | 30,592 | 29,776 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 17.87% | -0.97% | -2.66% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 33.6x | 28.3x | 23.3x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.1x | 9.28x | 7.14x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.7x | 1.5x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.05x | 5.46x | 4.9x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.91x | 5.27x | 4.61x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 18.5x | 15.9x | 13.4x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 24.8x | 21.2x | 17.3x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 30.2x | 25.1x | 20.3x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.31% | 3.99% | 4.93% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.495 | 2.969 | 3.596 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,230 | 5,800 | 6,461 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,666 | 1,920 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,247 | 1,445 | 1,722 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 974.4 | 1,149 | 1,409 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 83.88 | 83.88 | 83.88 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 2/10/22 A | 2/9/23 A | 2/8/24 A | 2/13/25 A | 2/12/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.88x | 5.95x | 18.69x | -.--% | 31.65B | |
| 30.27x | 4.11x | 15.78x | 2.44% | 182B | |
| 19.54x | 3.57x | 12.75x | 3.07% | 118B | |
| 17.78x | 0.21x | 12.97x | 0.74% | 61.7B | |
| 28.6x | 7.04x | 18.13x | 1.4% | 50.55B | |
| 34.51x | 3.35x | 11.49x | 2.19% | 48.98B | |
| 44.79x | 1.3x | 12.02x | 0.21% | 29.87B | |
| 39.39x | 6.89x | 24.74x | 0.27% | 23.71B | |
| 17.34x | 2.76x | 9.79x | 1.6% | 21.78B | |
| 48.56x | 6.57x | 21.11x | 0.44% | 21.55B | |
| Average | 31.47x | 4.17x | 15.75x | 1.23% | 58.94B | |
| Weighted average by Cap. | 28.52x | 3.89x | 15.02x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
